Medication info
Tegliam Extended-Release Tablet 10/750 mg

Tegliam Extended-Release Tablet 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
Shinil Pharmaceutical Co., Ltd.
Appearance
Yellow oval extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201313 · Approved 2022.04.04 · Insurance code 653806040

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse effects associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be monitored closely and the dose adjusted appropriately. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Since such a change may cause changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Shinil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is prescribed to be used in conjunction with dietary control and exercise for patients with type 2 diabetes to help manage blood sugar levels through the combined use of teneligliptin and metformin. This improves blood sugar control, facilitating better management of health. This medication is used for effective blood sugar improvement.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse effects associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be monitored closely and the dose adjusted appropriately. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Since such a change may cause changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is used for treating diabetes, specifically aiding in blood sugar control. During the use of this medication, a very rare but serious side effect known as lactic acidosis can occur. Lactic acidosis is a condition resulting from an excessive buildup of lactic acid in the body, which can lead to life-threatening situations if left untreated, so caution is needed. Additionally, when used with other diabetes medications such as insulin or sulfonylureas, there is a risk for hypoglycemia, namely symptoms of excessively low blood sugar, thus careful monitoring of blood sugar levels is essential. Patients with moderate to severe renal impairment or conditions such as heart failure, acute myocardial infarction, or sepsis that may affect renal function should not use this medication. Patients who are scheduled to undergo tests using iodine-based contrast agents should stop taking this medication 48 hours before the test and can resume after verifying normal renal function post-examination. This medication is also not recommended for pregnant women or those who may become pregnant and patients with severe liver or lung dysfunction. Patients with a history of abdominal surgery or bowel obstruction, as well as those with a history of cardiac issues such as prolonged QT interval, should use this medication cautiously, and should consult a doctor immediately if acute pancreatitis symptoms occur. This medication contains Yellow No. 5 dye, so patients allergic to this component need to take caution. While taking this medication, patients should be well aware of hypoglycemic symptoms and take appropriate actions, such as consuming sugar-containing foods, if they suspect hypoglycemia. This medication can affect liver and kidney functions, so it is important to undergo regular blood tests and kidney function assessments. Particularly for elderly or patients with decreased kidney function, dose adjustments and regular monitoring of kidney function are necessary, and excessive alcohol consumption should be avoided. Additionally, this medication can lower vitamin B12 levels, so regular vitamin B12 testing is recommended for long-term users. Should severe joint pain or blistering skin symptoms appear during the usage of this medication, patients must inform their doctor immediately and seek treatment. In case of overdose, immediate hospital treatment is required, and if necessary, dialysis may be performed to remove the drug. Finally, this medication is not recommended for use in children and adolescents as safety and efficacy have not been established. During the administration of this medication, it’s essential to consult with a healthcare provider regularly and report any unusual symptoms immediately.

Side effects

Severe lactic acidosis, severe hypoglycemia, hypoglycemia, constipation, intestinal obstruction, liver dysfunction, interstitial pneumonia, similar pemphigoid, acute pancreatitis, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyps, colon polyps, duodenal ulcers, gastroesophageal reflux disease, diarrhea, loss of appetite, elevated amylase, elevated lipase, increased AST (GOT), increased ALT (GPT), elevated GGT, elevated ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, elevated CK (CPK), increased serum potassium concentration, fatigue, allergic rhinitis, elevated serum uric acid, shingles, limb pain, epigastric pain, gastritis, dizziness, upper respiratory infection, hypoglycemia, dizziness, tremors, headache, weakness, hunger, fatigue, facial edema, diarrhea, indigestion, nausea, viral upper respiratory infection, shingles, rhinitis, cold sweats, itching, diabetic retinopathy, reduced vision, cough, pulmonary congestion, dyspnea, drug overdose, prostatic hypertrophy, headache, nasopharyngitis, bone fracture, diarrhea, nausea, vomiting, decreased serum vitamin B12 concentration, cerebral infarction, hyperglycemia, uterine empyema, gastroenteritis, influenza, subcutaneous abscess, musculoskeletal chest pain, arthralgia, intervertebral disc degeneration, falls, animal bites, distal radius fracture, chronic bronchitis, hypertrophy of the thyroid cartilage, hypertension, hearing loss, endolymphatic hydrops, vertigo, increased blood creatinine, increased blood urea, anemia, atrial fibrillation, hypothyroidism, pressure ulcer, cataract, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, coronary artery disease, unstable angina, angina, otalgia, iron deficiency anemia, food allergy, lip injury, contusion, urticaria

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, and it is advisable to keep it at a temperature between 1 to 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Yellow oval extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.